https://newsroom.notified.com/umea-biotech-incubator-en Umeå Biotech Incubator - PressRelease https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-lab-fair-fully-booked-in-just-three-hour Umeå Lab Fair was fully booked in just three hours. On May 7, 21 exhibitors will gather at Northern Sweden’s only dedicated life science lab fair, organised by Umeå Biotech Incubator. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-lab-fair-fully-booked-in-just-three-hour Mon, 04 May 2026 06:06:59 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/nil-medical-receives-patients-award-at-swedis Umeå‑based medtech company Nil Medical won the Patient’s Award 2026 at the MedTech4Health Innovation Award in Sweden. The award recognizes patient‑centered innovations, and Nil Medical was recognized for improving the everyday lives of children undergoing cancer treatment through its Nil Medical Vestpack. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/nil-medical-receives-patients-award-at-swedis Wed, 15 Apr 2026 09:32:28 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/spinchem-expands-in-indias-pharma-market-with Sweden-based SpinChem expands its presence in India through a new partnership with Smart Labtech, meeting rising demand for scalable biocatalysis as India's fast‑growing pharma industry accelerates its shift toward greener and more efficient production processes. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/spinchem-expands-in-indias-pharma-market-with Fri, 27 Feb 2026 06:45:21 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-self-sampling-pioneer-wins-landmark-d Swedish self-sampling pioneer Direkttest is expanding internationally, securing a major Swedish research contract while exploring entry into Dubai and the UAE. With growing demand for cost-efficient capillary self-sampling, the company is strengthening its position in the life science and digital diagnostics sector. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-self-sampling-pioneer-wins-landmark-d Fri, 20 Feb 2026 06:30:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/nil-medical-named-finalist-in-swedish-innovat Umeå based Nil Medical AB has been selected as a finalist in the Swedish "Medtech4Health Innovation Award" for its Vestpack, an infusion vest designed to make everyday life easier for children and young people undergoing medical treatment. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/nil-medical-named-finalist-in-swedish-innovat Wed, 18 Feb 2026 08:04:49 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/iso-certification-strengthens-spinchems-rbr-t Swedish-based SpinChem AB has achieved ISO 9001:2015 certification for its RBR technology, marking a key milestone for applications in pharmaceuticals, biotech and nuclear‑related purification. The accreditation strengthens the company’s standing in high‑demand, regulated industries. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/iso-certification-strengthens-spinchems-rbr-t Wed, 04 Feb 2026 07:46:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-reindeer-lichen-project-gains-mining The Swedish company Boreal Orchards will develop methods to restore reindeer lichen in disturbed mining landscapes. The project, ”symbios”, is funded with SEK 15.5 million and supported by the Swedish Innovation Agency, four mining companies (including Teck Resources Limited), and the Swedish Sami Association. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-reindeer-lichen-project-gains-mining Mon, 02 Feb 2026 07:56:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/manufacturing-collaboration-strengthens-life Diamyd Medical expands its biomanufacturing strategy in Umeå through collaborations with APL and NorthX Biologics, strengthening northern Sweden’s life science ecosystem and advancing production of the type 1 diabetes drug candidate retogatein (rhGAD65). tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/manufacturing-collaboration-strengthens-life Mon, 26 Jan 2026 09:35:39 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-biotech-incubator-awards-grants-for-four Four high‑impact research projects have been selected to receive Umeå Biotech Incubator’s “killer experiment” funding, totaling SEK 970,000. The support enables decisive experiments that could unlock breakthroughs in cancer treatment, antiviral strategies, and the detection of blood manipulation. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-biotech-incubator-awards-grants-for-four Wed, 17 Dec 2025 13:32:26 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-ab-granted-swedish-patent-for-antimi Mucocort AB has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its innovative treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis). tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-ab-granted-swedish-patent-for-antimi Thu, 11 Dec 2025 07:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/prediktera-marks-10-years-with-42-revenue-gro Prediktera, founded as a Umeå University spin-off, has grown into a global technology partner helping industries improve quality control and streamline production with advanced spectral imaging software. The company is expanding, and the revenue grew by 42 percent between 2023 and 2024. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/prediktera-marks-10-years-with-42-revenue-gro Wed, 03 Dec 2025 09:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/spinchem-launches-new-lab-reactor-to-boost-ma The Umeå company SpinChem launches the MiniRBR, a refillable lab-scale reactor for rapid screening and scale-up in biocatalysis and solid–liquid processes. Operating from just 5 mL, it boosts mass transfer, saves time, and delivers results comparable to larger reactors. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/spinchem-launches-new-lab-reactor-to-boost-ma Mon, 01 Dec 2025 10:28:16 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/cropcision-appoints-jonas-gullberg-as-head-of The Swedish Agtech company Cropcision appoints Jonas Gullberg as Head of Business Development & Sales. He will lead the launch of Silvivo, a precision nutrient for forestry that strengthens roots, improves survival, and boosts resilience in tough conditions tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/cropcision-appoints-jonas-gullberg-as-head-of Wed, 12 Nov 2025 09:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/metacurums-cancer-strategy-backed-by-scientif Researchers from Umeå and Uppsala universities, led by Maréne Landström, founder of MetaCurUm Biotech, have identified seven blood-based biomarkers that can detect clear cell renal cell carcinoma. The results strengthen the scientific basis for MetaCurUm’s drug development. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/metacurums-cancer-strategy-backed-by-scientif Thu, 02 Oct 2025 07:03:54 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-medtech-company-receives-prestigious Nil Medical AB has been awarded one of Sweden’s most prestigious design prizes, Utmärkt Svensk Form 2025, for its infusion vest, the Nil Medical Vestpack. The Vestpack is a patented, CE-marked ergonomic garment that safely integrates infusion system components (fluids, pumps, and tubing) within the vest itself. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-medtech-company-receives-prestigious Tue, 16 Sep 2025 11:52:15 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-childhood-cancer-fund-establishes-imp The Swedish Childhood Cancer Fund has launched a new impact venture: Barncancerfonden Impact Invest AB. The first investment is in Nil Medical AB, which has developed Vestpack – a patented, CE-marked ergonomic vest designed to protect infusion system components. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-childhood-cancer-fund-establishes-imp Wed, 10 Sep 2025 12:35:08 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/ai-to-help-uncover-blood-doping-swedish-firm ProTest Diagnostics, a Swedish biotech company, has secured a significant grant from the World Anti-Doping Agency (WADA) to develop cutting-edge technology aimed at detecting one of sport’s hardest-to-spot cheating methods – blood doping. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/ai-to-help-uncover-blood-doping-swedish-firm Thu, 14 Aug 2025 08:15:51 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/cropcision-secures-financing-to-scale-plastic Swedish agtech company Cropcision has secured funding from Northern Light Capital and Partnerinvest Norr. The company develops plastic-free, controlled-release fertilizers that meet upcoming EU regulations – and is now preparing for international expansion. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/cropcision-secures-financing-to-scale-plastic Tue, 01 Jul 2025 12:39:05 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/experienced-rd-leader-appointed-coo-at-nil-me Growing demand for the infusion vest, Nil Medical Vestpack, has prompted Umeå-based Nil Medical AB to expand its leadership team. Malin Walfridsson, former Head of R&D at Nordic Biomarker, has joined the company as COO and Deputy CEO. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/experienced-rd-leader-appointed-coo-at-nil-me Tue, 10 Jun 2025 09:53:49 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/omnio-raises-43-million-to-accelerate-wound-h Omnio AB, a Umeå-based biotech company focused on innovative treatments for chronic wounds, has secured a major capital injection from current shareholders. “This support allows us to complete our GMP manufacturing process and move toward clinical trials,” says newly appointed CEO Felipe Velasquez. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/omnio-raises-43-million-to-accelerate-wound-h Tue, 20 May 2025 06:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/vakona-secures-financing-to-advance-groundbre Umeå-based biotech company Vakona has raised new capital from a combination of existing shareholders and four new private investors. The funds will enable the company to complete the process development of its innovative active substance as it moves toward the clinical phase. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/vakona-secures-financing-to-advance-groundbre Mon, 28 Apr 2025 04:06:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/roger-folkhage-appointed-new-ceo-of-medicvent Roger Folkhage has been appointed as the new CEO of the Umeå-based company Medicvent. He joins from his previous role as Global Sales Director at Bohus Biotech. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/roger-folkhage-appointed-new-ceo-of-medicvent Thu, 10 Apr 2025 04:35:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-biotech-incubator-receives-sek-25-millio-1 Umeå Biotech Incubator (UBI) has been awarded 2.5 million SEK in continued support from Kempestiftelserna for 2026. These funds are designated to assist verification activities for researchers and projects associated with UBI. "We are pleased and grateful to receive continued trust from Kempestiftelserna. These funds provide researchers at, among others, Umeå University a unique opportunity to commercialize their research through UBI" states Peter Jacobsson, Acting Operations Manager at UBI. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-biotech-incubator-receives-sek-25-millio-1 Tue, 08 Apr 2025 05:42:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/nil-medical-scales-up-to-reach-more-patients Nil Medical's medical infusion vest, the "Nil Medical Vestpack," is being tested at five hospitals in Sweden as part of a clinical trial. Now, the company is looking to hire a Business & Sales Manager. "To achieve our goal of making the vest available to more children and hospitals, we need to grow our team," says Martin Hanberger, CEO and founder of Nil Medical. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/nil-medical-scales-up-to-reach-more-patients Wed, 19 Mar 2025 10:57:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/quretech-bio-granted-european-patent-for-new QureTech Bio AB has been granted a patent by the European Patent Office (EPO) for GmPcides, a new class of synthetic antibacterials. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/quretech-bio-granted-european-patent-for-new Sat, 08 Mar 2025 07:46:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-ab-strengthens-global-position-with Mucocort AB has successfully developed M045A, an innovative mucoadhesive "patch" for the treatment of oral aphthous ulcers. The company has now been granted a patent in Australia for its medical technology innovation, marking a significant milestone in its international expansion. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-ab-strengthens-global-position-with Tue, 04 Mar 2025 12:08:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/lina-olsson-joins-prevas-as-business-unit-man Lina Olsson, former CEO of HiloProbe, is stepping into a new role as Business Unit Manager at the consulting firm Prevas. The company is expanding into Umeå focusing on MedTech and Life Science. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/lina-olsson-joins-prevas-as-business-unit-man Wed, 26 Feb 2025 07:05:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/ubi-business-coach-steps-in-as-ceo-for-ki-sta Patient Safety Surveillance Solutions (P3S) is developing software that automatically monitors healthcare-associated injuries. Now, Tobias Tovedal, a business coach at Umeå Biotech Incubator (UBI), is stepping in as the new CEO of the Karolinska Institutet (KI) startup. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/ubi-business-coach-steps-in-as-ceo-for-ki-sta Mon, 17 Feb 2025 06:45:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-biotech-incubator-granted-sek-146-millio Umeå Biotech Incubator (UBI) has once again been designated as an excellent incubator by the Swedish Innovation Agency, Vinnova, and has been awarded SEK 14.6 million in excellence funding, ensuring financial support through 2029. “This confirms that Vinnova has confidence in our work and our ability to help startups thrive,” says Peter Jacobsson, Acting Head of Operations of UBI. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/umea-biotech-incubator-granted-sek-146-millio Thu, 06 Feb 2025 07:48:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/hilicons-record-turnover-fuels-next-gen-chrom Success didn’t come overnight, but ten years after its founding, Umeå-based HILICON has built a solid presence in 40 countries. The company is making its mark in the chromatography industry with consistent revenue growth and innovative products in the pipeline. "My dream is to double the turnover in a few years," says Wen Jiang, CEO and founder of HILICON. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/hilicons-record-turnover-fuels-next-gen-chrom Mon, 09 Dec 2024 05:54:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/metacurum-secures-sek-1-million-grant-for-can MetaCurUm AB has been awarded one million SEK from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative. "This support is crucial for us as it brings us closer to securing additional funding that will help us advance to clinical trials," says CEO Maarten de Château. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/metacurum-secures-sek-1-million-grant-for-can Thu, 05 Dec 2024 07:14:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/four-pilot-projects-to-lead-the-way-in-bridge BRIDGE Sweden aims to streamline the journey from research to commercialization in biologics and precision medicine. Four standout pharmaceutical pilot projects, chosen for their scientific excellence and innovative potential, will play a pivotal role in advancing this initiative. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/four-pilot-projects-to-lead-the-way-in-bridge Wed, 04 Dec 2024 08:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-moss-innovator-joins-global-leaders-a From December 2-13, Daniel Pacurar, an eco-tech innovator from northern Sweden, will join global leaders in Riyadh, Saudi Arabia, for UNCCD COP16, a climate conference focused on combating drought and desertification. Daniel has been invited to hold a seminar to present the re:moss concept. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-moss-innovator-joins-global-leaders-a Sun, 24 Nov 2024 10:24:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/leadership-change-ahead-as-medicvents-ceo-tra The Umeå-based company Medicvent is seeking a new CEO as Erik Lindström transitions to a new role within the parent group, Sdiptech. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/leadership-change-ahead-as-medicvents-ceo-tra Thu, 14 Nov 2024 11:45:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-receives-additional-patent-approval Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC). “This approval is a significant step forward in our global growth strategy”, states Jean Lycke, Project Manager at Mucocort AB. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-receives-additional-patent-approval Mon, 21 Oct 2024 07:51:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/plastic-free-fertilizers-from-swedish-startup The European sunflower market is facing disruptions and seeking new solutions. Cropcision, a Swedish AgTech startup, has the potential to contribute to this evolving landscape. Their plastic-free precision fertilizers will be tested in a sunflower trial, supported by EIT Food, in Spain in 2025. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/plastic-free-fertilizers-from-swedish-startup Mon, 14 Oct 2024 09:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/experienced-life-science-leader-joins-diamyd Sofia Mayans, who transitioned from her research to co-founding the award-winning company InfiCure Bio, is taking on a new role as Director of Business Development at Diamyd Medical in Umeå. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/experienced-life-science-leader-joins-diamyd Tue, 24 Sep 2024 03:44:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/quretech-bio-secures-major-investment-from-ke QureTech Bio has received a substantial investment from Kempestiftelserna. A total of SEK 14 million is invested in the company by Kempestiftelserna along with the company’s largest shareholder, Nascent Invest. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/quretech-bio-secures-major-investment-from-ke Mon, 23 Sep 2024 06:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/experienced-ceo-appointed-chairman-of-umea-bi Urban Eriksson has been appointed as the new Chairman of the board for Umeå Biotech Incubator. tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/experienced-ceo-appointed-chairman-of-umea-bi Fri, 20 Sep 2024 04:07:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/global-push-for-medical-vest-that-aims-to-ena For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility. Umeå based Nil Medical has developed an ergonomic medical vest that conceals fluids, pu tomas.ruuth@ubi.se (Tomas Ruuth) https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/global-push-for-medical-vest-that-aims-to-ena Wed, 11 Sep 2024 05:20:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-biotech-company-alexotech-achieves-re Swedish biotech company AlexoTech set a new turnover record in 2023 and predicts another strong performance this year. Citing Agrisera as a local role model, CEO and founder Anders Olofsson believes there are plenty of opportunities for the Umeå-based company to expand. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/swedish-biotech-company-alexotech-achieves-re Fri, 06 Sep 2024 07:29:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/quretech-bio-appoints-new-ceo-strive-to-bring Umeå based QureTech Bio, a biotechnology company developing novel antibiotics and anti-infectives, has appointed Markus Thor as the new Chief Executive Officer. “Along with the team, I will strive to bring our substances to clinical trials”, he states. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/quretech-bio-appoints-new-ceo-strive-to-bring Tue, 03 Sep 2024 08:05:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/new-ubi-case-aims-to-revolutionize-treatment Cryptosporidiosis is one of the biggest threats to newborn calves in the global agricultural industry. It is also responsible for hundreds of thousands of human deaths in developing countries each year. There is currently no effective treatment for the disease, but a new case at Umeå Biotech Incubator is set to change that. Professor Christian Hedberg is developing a new drug with the potential to revolutionize the treatment of cryptosporidiosis worldwide. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/new-ubi-case-aims-to-revolutionize-treatment Mon, 17 Jun 2024 05:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/hiloprobe-secures-3-sek-million-in-funding-fo Umeå based HiloProbe has raised an additional SEK 3 Million in funding from existing owners. This capital injection is a step towards achieving the next goal. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/hiloprobe-secures-3-sek-million-in-funding-fo Tue, 11 Jun 2024 07:12:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/sek-22-million-in-eu-funding-elevates-the-lif Umeå is strengthening its position as a life science hub thanks to two regional development projects receiving around €1.8 million (22 SEK million) in EU support. These projects aim to boost innovation, collaboration, and industry growth. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/sek-22-million-in-eu-funding-elevates-the-lif Mon, 03 Jun 2024 08:42:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/metacurum-aims-to-raise-sek-100-million---fol Maréne Landström, a professor of pathology at Umeå University, was named Sweden's Cancer Researcher of the Year for 2024. Her groundbreaking research is currently being developed into a cancer treatment by the company MetaCurUm, which is now gearing up to raise new capital for its next phase. "MetaCurUm is aiming to secure around 100 million SEK, with substantial interest already shown by institutional investors in Sweden and Europe”, says, CEO Maarten de Château. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/metacurum-aims-to-raise-sek-100-million---fol Thu, 23 May 2024 11:02:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-initiates-clinical-trial-of-innovati Mucocort AB has received approval from the Swedish Medical Products Agency and the Ethics Review Board to commence a clinical trial of an intraoral patch (M045A) for the treatment of aphthous stomatitis, a condition affecting approximately 2 percent of the population and causing frequent mouth ulcers with significant pain for affected patients. "We are pleased to soon be ready to welcome our first patient to the trial," says Jean Lycke, project manager for Mucocort AB. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/mucocort-initiates-clinical-trial-of-innovati Tue, 07 May 2024 06:00:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/spinchem-joins-trailblazing-alliance-we-can-m SpinChem joins the Enzyme Technology Alliance - a group of six trailblazing European companies, collaborating to bring competitive solutions for the biotech industry to market at scale. “In the Alliance, we can tackle complex challenges and offer solutions previously unimaginable”, says Emil Byström, CEO of SpinChem. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/spinchem-joins-trailblazing-alliance-we-can-m Mon, 06 May 2024 08:05:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/new-lab-fair-attracts-18-companies-to-umea Lab companies often visit Umeå one at a time. That's why Umeå Biotech Incubator (UBI) organizes the Umeå Lab Fair on the 25th of April, featuring 18 participating companies. "By bringing everyone together on the same occasion, we create added value for exhibitors and visitors", says Christin Grundström, Laboratory and Community Manager at UBI. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/new-lab-fair-attracts-18-companies-to-umea Tue, 23 Apr 2024 06:25:00 GMT https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/bridge-project-aims-to-strengthen-swedish-pat A 7.7 million SEK investment is being made into the BRIDGE Sweden project, designed to streamline the journey from research to commercialization of biological pharmaceuticals and precision medicine. The initiative will more closely integrate research infrastructure with innovation systems and develop new cell lines on SciLifeLab's Drug Discovery and Development (DDD) platform, furthering the scale-up process at Testa Center. https://newsroom.notified.com/umea-biotech-incubator-en/posts/pressreleases/bridge-project-aims-to-strengthen-swedish-pat Tue, 26 Mar 2024 07:22:00 GMT